Abstract
A proposal to adopt a Pharmaceutical Evaluation Report (PER) scheme for regulatory dialogue in the Asia-Pacific Economic Cooperation (APEC) region was made from Taiwan in the APEC Life Science Innovation Forum (LSIF) in Peru in 2008, aiming to overcome the heterogeneous situation. The PER scheme was recommended to the APEC leadership. The history of the PER scheme, the reasons why the scheme is needed, and its benefits are discussed.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
